로딩 중…
지수 로딩 중…
Bioneer Corporation
064550· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩7,160-6.53%
2026-06-19
Price Chart
Bioneer Corporation-52.74%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 184.80B KRW |
| Revenue | 338.01B KRW |
| Net Income | 1.71B KRW |
| Total Assets | 368.98B KRW |
| Net Assets | 218.22B KRW |
| Employees | 392 |
| Value | |
| P/E | 108.26x |
| P/B | 0.85x |
| P/S | 0.55x |
| EV/EBITDA | 22.72x |
| FCF Yield | -37.66% |
| Profitability | |
| ROE | 0.78% |
| ROA | 0.46% |
| Op. Margin | 3.06% |
| Revenue Growth | 10.69% |
| Financial Health | |
| Debt Ratio | 169.08% |
| Total Debt | 104.91B KRW |
| FCF | -69.59B KRW |
| Cash | 54.37B KRW |
| Current Ratio | 2.04x |
| Net Debt/EBITDA | 4.88x |
| Dividend | |
| Div. Yield | 2.38% |
| Performance | |
| 1Y Return | -52.74% |
| 1M Return | -28.76% |
| From 52W High | -58.37% |
| 1Y MDD | -56.68% |
| Trading | |
| Volume | 162,215 shares |
| Foreign Own. | 6.43% |
| Per Share | |
| EPS | -226 KRW |
| BPS | 7,960 KRW |
Company Info
Established in 1992 as the first researcher startup from the Korea Research Institute of Bioscience and Biotechnology, the company is a genetic engineering specialist listed on KOSDAQ in 2005. It operates diverse bio-healthcare businesses, including life science research equipment, reagents, molecular diagnostics, and synthetic biology. The company is developing a next-generation molecular diagnostics platform and a SAMiRNA new drug development platform to pursue global market entry. It also reinvests in research and development and expands its business portfolio through technological innovation. Bioneer is headquartered in Yuseong-gu, Daejeon.